Insiders AstraZeneca PLC

Stocks

AZN

GB0009895292

Pharmaceuticals

Market Closed - London S.E. Other stock markets 11:35:09 2026-07-13 am EDT			5-day change	1st Jan Change
12,610.00 ^GBX	-1.75%		-12.77%	-8.56%

Jul. 13	European Equities Traded in US as ADRs Decline	MT
Jul. 13	HSBC Downgrades AstraZeneca to Hold Rating, Cuts PT	MT

Insiders

Jul. 09	AstraZeneca's Rare Drug Trial Failure Sends Shares Plunging	MT
Jun. 05	AstraZeneca Broadens US Growth Push	MT
Apr. 23	Astrazeneca plc Announces Stepping Down of Rene Haas as Non-Executive Director, Effective April 30, 2026	CI
Feb. 24	AstraZeneca PLC Announces Directorate And Committee Changes, Effective April 9, 2026	CI
Feb. 24	AstraZeneca announces retirement of non-executive director Nazneen Rahman	RE
Feb. 11	China charges former AstraZeneca regional head Leon Wang	RE
Jan. 13	AstraZeneca CFO on M&A Strategy and Obesity Market	MT
Jan. 08	AstraZeneca Appoints Rick R. Suarez As Senior Vice President, US President, And Head Of US BioPharmaceuticals Business Unit	CI
Jan. 08	Joris Silon appointed head of investor relations at AstraZeneca
Jan. 08	Astrazeneca Names Rick Suarez Head of US BioPharmaceuticals Unit	MT
Jan. 08	AstraZeneca names insider Rick Suarez as head of US biopharmaceuticals unit	RE
Jan. 08	AstraZeneca names Rick Suarez head of US biopharmaceuticals unit	RE
Jan. 08	AstraZeneca plc Announces Executive Changes , Effective March 1, 2026	CI
Dec. 22	Jacobio Strikes New Cancer Drug Deal with AstraZeneca	MT
Dec. 01	Faron appoints former AstraZeneca Netherlands finance chief as CFO	AN
Nov. 17	Hims & Hers names ex-FDA official Deb Autor as first policy chief	RE
Nov. 06	AstraZeneca Profit Beats Estimates on Cancer, Diabetes Drugs	MT
25-07-29	US Expansion Not Driven By Tariffs: AstraZeneca CFO	MT
25-07-29	AstraZeneca Profit, Revenue Lifted by Cancer Drugs	MT
25-05-21	AstraZeneca chief executive joins Agilent Technologies board	AN
25-04-29	AstraZeneca Gets Profit Boost From Diabetes, Cancer Drugs	MT
25-04-11	AstraZeneca PLC Appoints Karen Knudsen as Director	CI
25-03-21	AstraZeneca investing $2.5 billion in China as drugmaker seeks to recover from scandals	RE
25-03-21	AstraZeneca investing $2.5 billion in China as drugmaker seeks to recover from scandals	RE
25-02-18	AstraZeneca PLC Announces Board and Committee Changes	CI